https://www.selleckchem.com/pr....oducts/zidesamtinib.
success in such severe cases. Claudication has a relatively benign natural history, associated with a low risk of limb loss. However, rates of progression to chronic limb-threatening ischemia (CLTI) following lower extremity revascularization (LER) for claudication remain unclear. This study examines the long-term outcomes and risk factors associated with progression to CLTI after LER for claudication. A single-center retrospective review of patients undergoing LER for claudication was performed from 2013-2016. Patients were strati
Like
Comment
Share
